Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)
用户slK1Kxicm8Dw
42分钟前
7
10
求助中
帖子自动结束时间: 2025-12-09 23:02:45
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性，不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1182/blood-2023-174420
其他信息:
出版社: American Society of Hematology
作者: Wei Yang; Sujun Gao; Xiaojing Yan; Rong Guo; Lijie Han; Fei Li; Yafei Wang; Junmin Li; Chunkang Chang; Haiping Yang; Ronghua Hu; Hongyan Tong; Xingli Zhao; Qiubai Li; Jingdong Zhang; Xin Du; Sanfang Tu; Cheng Zhang; Congmeng Lin; Xin Du; Zhenling Li; Ligen Liu; Zhenyu Li; Zheng Dong; Yixuan Yang; Qiying Lu; Wenzhi Tian; Zhijian Xiao
全文下载地址: https://ashpublications.org/blood/article-pdf/142/Supplement%201/320/2199037/blood-4924-main.pdf
